CHROMADEX CORPORATION (NASDAQ:CDXC) Files An 8-K Other Events
Item 8.01. Other Events.
certain previously nonpublic information about the Company in its
corporate presentation, which the Company is making available on
its website.
Exhibit 99.1. The foregoing is incorporated herein by reference
and constitutes part of this report.
|
Item9.01.
|
Financial Statements and Exhibits.
|
|
Exhibit
No.
|
Description
|
|
|
99.1
|
Investor Presentation of ChromaDex Corporation
|
|
About CHROMADEX CORPORATION (NASDAQ:CDXC)
Chromadex Corporation and its subsidiaries ChromaDex, Inc., ChromaDex Analytics, Inc. and Spherix Consulting, Inc. provide research and quality-control products and services to the natural products industry. The Company allows its business units to discover, acquire, develop and commercialize ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The Company operates through three segments: Ingredients, which develops, supplies and commercializes ingredient technologies; Core standards and contract services, which supplies phytochemical reference standards, which are small quantities of plant-based compounds used to research an array of attributes, reference materials and related contract services, and Scientific and regulatory consulting, which provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage health and regulatory risks. CHROMADEX CORPORATION (NASDAQ:CDXC) Recent Trading Information
CHROMADEX CORPORATION (NASDAQ:CDXC) closed its last trading session down -0.06 at 2.33 with 47,161 shares trading hands.
